Reliq Health Technologies Inc. RQHTF
OTC PK
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 107.91% | 159.51% | 257.97% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 107.91% | 159.51% | 257.97% | -- | -- |
| Cost of Revenue | 184.36% | 277.60% | 328.87% | -- | -- |
| Gross Profit | 76.79% | 112.83% | 223.34% | -- | -- |
| SG&A Expenses | -42.98% | -52.64% | -41.83% | -- | -- |
| Depreciation & Amortization | -37.35% | -30.05% | -30.96% | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.93% | -7.06% | -7.09% | -- | -- |
| Operating Income | 85.42% | 76.13% | 64.62% | -- | -- |
| Income Before Tax | 94.87% | 82.76% | 69.67% | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 94.87% | 82.76% | 69.67% | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 94.87% | 82.76% | 69.67% | -- | -- |
| EBIT | 85.42% | 76.13% | 64.62% | -- | -- |
| EBITDA | 86.12% | 76.59% | 65.07% | -- | -- |
| EPS Basic | 94.51% | 83.27% | 72.49% | -- | -- |
| Normalized Basic EPS | 94.25% | 83.38% | 72.84% | -- | -- |
| EPS Diluted | 94.51% | 83.27% | 72.49% | -- | -- |
| Normalized Diluted EPS | 94.25% | 83.38% | 72.84% | -- | -- |
| Average Basic Shares Outstanding | 2.63% | 6.49% | 10.19% | -- | -- |
| Average Diluted Shares Outstanding | 2.63% | 6.49% | 10.19% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |